Home
About
Overview
Sharing Data
ORCID
Help
History (19)
TNP-470 promotes initial vascular sprouting in xenograft tumors.
Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer.
Implications of lemuriform extinctions for the Malagasy flora.
A pH-Triggered, Self-Assembled, and Bioprintable Hybrid Hydrogel Scaffold for Mesenchymal Stem Cell Based Bone Tissue Engineering.
Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer.
Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer. Curr Treat Options Oncol. 2018 11 15; 19(12):1.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Benzimidazoles
BRCA1 Protein
BRCA2 Protein
Carbazoles
Female
Humans
Indazoles
Indoles
Neoplasm Recurrence, Local
Ovarian Neoplasms
Ovary
Phthalazines
Phthalimides
Piperazines
Piperidines
Poly(ADP-ribose) Polymerase Inhibitors
authors with profiles
Katherine Kurnit